US Endovascular is a Midwest based medical device company established in 2014 to address the needs of healthcare providers in this dynamic market. The US Endovascular team, with over 70 years of combined experience, recognizes the traditional relationship between device company/manufacturer & healthcare provider must change in order to reduce costs.
The fundamental premise of US Endovascular is to obtain next-generation clinically-relevant devices from manufacturers on an exclusive basis, and provide them directly to the end user, economic buyer or corporate partner. This approach substantially reduces costs by eliminating unnecessary layers and processes.
The Company's streamlined and efficient sales and marketing approach positions them to rapidly gain market share in today’s complex demanding environment. Converging market forces within healthcare, consolidation and the demand for high quality at low cost aligns with the company’s low overhead distribution model (traditional SG&A costs removed). By focusing on relationships with large healthcare providers & delivery networks, aligning with complimentary device companies, and partnering with a world-class logistics organization, USE can maximize efficiencies and optimize value.
A developing portfolio of high quality complimentary products, specifically peripheral angioplasty balloons, peripheral wires and robust pipeline of next generation technology provides USE with the unique ability to highlight line-by-line savings, bundle and restrain competitors. Clinical support and product implementation teams dedicated to providing solutions are fundamental to the strategy.
USE is ideally positioned to leverage its superior sales channels, streamline the sales/distribution process and change the paradigm.